2 Bay Area biotechs set to test IPO market: Virobay, Atara Biotherapeutics
October 13, 2014 at 10:32 AM EDT
The Bay Area's fourth-quarter IPO season swings back into action with a pair of biotech offerings this week from Atara Biotherapeutics and Virobay...